Significant antitumour effect of an antibody against TMEM180, a new cancer-specific molecule
Masahiro Yasunaga, Shinji Saijou, Shingo Hanaoka, Takahiro Anzai, Ryo Tsumura, Yasuhiro Matsumura
The paper identifies TMEM180 as a CRC-specific molecule and shows that an anti-TMEM180 antibody eradicates CRC xenografts in mice.
bioRxiv · Aug 28, 2018 · PreprintCancer Biology